Does TAFASITAMAB Cause Covid-19 pneumonia? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Covid-19 pneumonia have been filed in association with TAFASITAMAB (MONJUVI). This represents 2.4% of all adverse event reports for TAFASITAMAB.
34
Reports of Covid-19 pneumonia with TAFASITAMAB
2.4%
of all TAFASITAMAB reports
10
Deaths
19
Hospitalizations
How Dangerous Is Covid-19 pneumonia From TAFASITAMAB?
Of the 34 reports, 10 (29.4%) resulted in death, 19 (55.9%) required hospitalization, and 2 (5.9%) were considered life-threatening.
Is Covid-19 pneumonia Listed in the Official Label?
Yes, Covid-19 pneumonia is listed as a known adverse reaction in the official FDA drug label for TAFASITAMAB.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
General physical health deterioration (75)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
What Other Drugs Cause Covid-19 pneumonia?
RITUXIMAB (1,489)
DEXAMETHASONE (758)
LENALIDOMIDE (750)
PREDNISONE (749)
OCRELIZUMAB (669)
TACROLIMUS (622)
MYCOPHENOLATE MOFETIL (594)
PREDNISOLONE (479)
METHOTREXATE (472)
CYCLOPHOSPHAMIDE (430)
Which TAFASITAMAB Alternatives Have Lower Covid-19 pneumonia Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR